Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-13,358
Closed -$153K 1673
2024
Q3
$153K Sell
13,358
-352
-3% -$3.99K ﹤0.01% 1434
2024
Q2
$137K Buy
+13,710
New +$153K ﹤0.01% 1371
2023
Q3
Sell
-23,812
Closed -$277K 1482
2023
Q2
$277K Sell
23,812
-62,469
-72% -$759K 0.01% 1183
2023
Q1
$1.03M Buy
86,281
+65,497
+315% +$722K 0.02% 685
2022
Q4
$205K Buy
+20,784
New +$201K ﹤0.01% 1221
2022
Q3
Sell
-29,870
Closed -$352K 1479
2022
Q2
$352K Buy
+29,870
New +$358K 0.01% 1045
2021
Q3
Sell
-31,353
Closed -$359K 1594
2021
Q2
$359K Buy
31,353
+4,153
+15% +$51.8K 0.01% 1166
2021
Q1
$335K Buy
+27,200
New +$328K 0.01% 1123

Other funds holding ORAN

Oppenheimer & Co's ORAN Position: Q4 2024 in Review

Oppenheimer & Co sold out of Orange (ORAN) in Q4 2024, closing a stake of 13,358 shares — an estimated $153K sold.

Oppenheimer & Co first reported a position in ORAN in Q1 2021 and held it in 8 quarters. The position peaked at $1.03M in Q1 2023. 46 funds tracked by Wall St. Rank hold ORAN as of Q4 2024.

  • Oppenheimer & Co reported no remaining Orange position as of Q4 2024 after selling out during the quarter.
  • Oppenheimer & Co sold 13,358 Orange shares in Q4 2024, an estimated $153K.
  • Oppenheimer & Co first reported a position in Orange in Q1 2021 and held it in 8 quarters.
  • Oppenheimer & Co's Orange position peaked at $1.03M in Q1 2023.
  • 46 funds tracked by Wall St. Rank held Orange as of Q4 2024.

Based on Oppenheimer & Co's 13F filing for Q4 2024, filed 5 Feb 2025.